Correlation Between Lexaria Bioscience and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both Lexaria Bioscience and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lexaria Bioscience and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lexaria Bioscience Corp and Eliem Therapeutics, you can compare the effects of market volatilities on Lexaria Bioscience and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lexaria Bioscience with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lexaria Bioscience and Eliem Therapeutics.
Diversification Opportunities for Lexaria Bioscience and Eliem Therapeutics
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Lexaria and Eliem is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Lexaria Bioscience Corp and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Lexaria Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lexaria Bioscience Corp are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Lexaria Bioscience i.e., Lexaria Bioscience and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between Lexaria Bioscience and Eliem Therapeutics
Assuming the 90 days horizon Lexaria Bioscience Corp is expected to generate 1.91 times more return on investment than Eliem Therapeutics. However, Lexaria Bioscience is 1.91 times more volatile than Eliem Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Eliem Therapeutics is currently generating about -0.21 per unit of risk. If you would invest 70.00 in Lexaria Bioscience Corp on September 1, 2024 and sell it today you would earn a total of 10.00 from holding Lexaria Bioscience Corp or generate 14.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lexaria Bioscience Corp vs. Eliem Therapeutics
Performance |
| Timeline |
| Lexaria Bioscience Corp |
| Eliem Therapeutics |
Lexaria Bioscience and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lexaria Bioscience and Eliem Therapeutics
The main advantage of trading using opposite Lexaria Bioscience and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lexaria Bioscience position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.| Lexaria Bioscience vs. Lexaria Bioscience Corp | Lexaria Bioscience vs. Lixte Biotechnology Holdings | Lexaria Bioscience vs. GeoVax Labs | Lexaria Bioscience vs. Reviva Pharmaceuticals Holdings |
| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |